Business Description
Gelesis Holdings Inc
NAICS : 541714
SIC : 2836
ISIN : US36850R2040
Compare
Compare
Traded in other countries / regions
GLSHQ.USA Index Membership
Russell 2000Russell 3000 IPO Date
2022-01-14Description
Gelesis Holdings Inc is a commercial-stage biotherapeutics company built for consumer engagement. The company is focused on advancing its superabsorbent hydrogel therapeutics for chronic gastrointestinal diseases, including excess weight, type 2 diabetes, non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH), functional constipation (FC), and inflammatory bowel disease. It manufactures and markets Plenity, which is based on a proprietary hydrogel technology, to aid in weight management when used in conjunction with diet and exercise. Geographically, the company operates out of the U.S. and Italy.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:GLSHQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Gelesis Holdings Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 12.14 | ||
| EPS (TTM) ($) | -0.7 | ||
| Beta | -107.7011 | ||
| 3-Year Sharpe Ratio | 0.44 | ||
| 3-Year Sortino Ratio | 2.73 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | 0.0001 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0.0001 - 0.0001 | ||
| Shares Outstanding (Mil) | 73.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Gelesis Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Gelesis Holdings Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Fourth quarter earnings results for 2026 | 2027-02-26 | In 181 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-15 | In 170 days | ||
| Fourth quarter earnings conference call for 2026 | 2027-02-15 | In 170 days | ||
| Second quarter earnings results for 2026 | 2026-09-04 | In 6 days | ||
| First quarter earnings results for 2026 | 2026-08-28 | 0.00 (+0.00%) |
Show
Entries
Gelesis Holdings Inc Frequently Asked Questions
What is Gelesis Holdings Inc(GLSHQ)'s stock price today?
The current price of GLSHQ is $0.00. The 52 week high of GLSHQ is $0.00 and 52 week low is $0.00.
When is next earnings date of Gelesis Holdings Inc(GLSHQ)?
The next earnings date of Gelesis Holdings Inc(GLSHQ) is 2026-09-04 Est..
Does Gelesis Holdings Inc(GLSHQ) pay dividends? If so, how much?
Gelesis Holdings Inc(GLSHQ) does not pay dividend.
Press Release
Articles on Gelesis Holdings Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers